SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Gigoptix, Inc.
GIG 10.57-0.1%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: RikRichter10/31/2006 9:52:31 AM
   of 148
 
InPlay
October 31, 2006
8:56AM Lumera: Harvard Medical School researchers to build next generation discovery and diagnostics methods with co's
ProteomicProcessor Biosensor (LMRA) 6.35 : Co announces that Harvard Medical School researchers are now building next generation discovery and diagnostics methods with it's ProteomicProcessor Biosensor. During the past year, Lumera has placed four beta units with highly respected, world renowned research organizations to demonstrate and establish new applications that take advantage of the instrument's unprecedented throughput in a label-free format. Harvard has served as a beta site for Lumera's biosensor platform, the ProteomicProcessor(TM), since mid-2006. The Harvard collaboration is focused on integrating their NAPPA (Nucleic Acid Programmable Protein Array) technology, which provides a simple and cost-effective way to generate a protein biochip, with the ProteomicProcessor(TM) to read and analyze the biochip.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News